> A first course in hemoadsorption therapy and systemic inflammation control
A first course in hemoadsorption therapy and systemic inflammation control in critically ill patients took place. On April 12, A first course of hemoadsorption and control of systemic inflammation in critical patients was held at the Palex Medical headquarters.
On April 12, a first course dedicated to the inflammatory mediators and organized by the Clinical Control Division took place. At Palex Medical headquarters, the clinical director in Cytsorbents Dr. Humbert exposed the importance of controlling the hyperinflammatory processes that are described in septic, surgical and transplant different scenes.
Attendees, ICU physicians, and heads of departments of the main hospitals in the East Area could share experiences with CRRT and purification therapies, including the Cytosorb hemoadsorbent column distributed by Palex, which one is mainly indicated for hydrophobic molecules removal and hemodynamic stabilization in critical care.